[
    [
        {
            "time": "2021-10-28",
            "original_text": "云南白药炒股票亏损15亿：企业投资不该玩“心跳”",
            "features": {
                "keywords": [
                    "云南白药",
                    "炒股亏损",
                    "15亿",
                    "心跳"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "云南白药炒股票亏损15亿：企业投资不该玩“心跳”",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-10-28",
            "original_text": "云南白药Q3净利润6.49亿元",
            "features": {
                "keywords": [
                    "云南白药",
                    "Q3",
                    "净利润",
                    "6.49亿"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "云南白药Q3净利润6.49亿元",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-10-28",
            "original_text": "利空来袭，主力资金砸盘，大白马紧急回应！",
            "features": {
                "keywords": [
                    "利空",
                    "主力资金",
                    "砸盘",
                    "大白马"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "利空来袭，主力资金砸盘，大白马紧急回应！",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-10-28",
            "original_text": "云南白药三季报踩雷，股价创年内新低",
            "features": {
                "keywords": [
                    "云南白药",
                    "三季报",
                    "踩雷",
                    "股价",
                    "年内新低"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "云南白药三季报踩雷，股价创年内新低",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-10-28",
            "original_text": "国盛证券维持云南白药买入评级：投资收益及激励费用等扰动导致短期业绩承压",
            "features": {
                "keywords": [
                    "国盛证券",
                    "云南白药",
                    "买入评级",
                    "投资收益",
                    "激励费用",
                    "短期业绩承压"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "国盛证券维持云南白药买入评级：投资收益及激励费用等扰动导致短期业绩承压",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]